RUBY - New medical chief at Rubius Therapeutics December, 23 2019 08:38 AM Rubius Therapeutics Inc. Rubius Therapeutics (NASDAQ:RUBY) appoints Christina Coughlin, M.D., Ph.D., as the Company’s Chief Medical Officer (CMO), effective January 6, 2020.More news on: Rubius Therapeutics, Inc., Healthcare stocks news, Read more ...